NGM Biopharmaceuticals Inc. (NGM) a clinical-stage biopharmaceutical company, engages in the discovery and development of novel therapeutics for the treatment of cardio-metabolic, liver, oncologic, and ophthalmic diseases. The company reported earnings on March 17, 2020 and provided an update on the progress of several drugs they’re developing. According to the CEO, David J. Woodhouse Ph.D.: […]